These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35662170)

  • 1. [Cutting edge of diagnosis and treatment of disseminated intravascular coagulation].
    Seki Y
    Rinsho Ketsueki; 2022; 63(5):441-453. PubMed ID: 35662170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of DIC associated with hematological malignancies].
    Seki Y
    Rinsho Ketsueki; 2018; 59(10):2212-2221. PubMed ID: 30305528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Combined Thrombomodulin and Antithrombin in Anticoagulant Therapy for Acute Cholangitis-induced Disseminated Intravascular Coagulation.
    Morita N; Nakahara K; Morita R; Suetani K; Michikawa Y; Sato J; Tsuji K; Ikeda H; Matsunaga K; Watanabe T; Matsumoto N; Okuse C; Suzuki M; Itoh F
    Intern Med; 2019 Apr; 58(7):907-914. PubMed ID: 30449812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies.
    Ikezoe T
    Int J Hematol; 2021 Jan; 113(1):34-44. PubMed ID: 32902759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and management of DIC complicated by hematological malignancies].
    Ikezoe T
    Rinsho Ketsueki; 2016; 57(10):2136-2144. PubMed ID: 27795523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
    Iba T; Thachil J
    Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant Therapy for Disseminated Intravascular Coagulation After Gastrointestinal Surgery.
    Hashimoto D; Okawa T; Maruyama R; Matsumura F; Shibata Y; Kohrogi H
    Anticancer Res; 2019 Jan; 39(1):25-31. PubMed ID: 30591437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anticoagulant treatment for sepsis induced disseminated intravascular coagulation; network meta-analysis.
    Yatabe T; Inoue S; Sakamoto S; Sumi Y; Nishida O; Hayashida K; Hara Y; Fukuda T; Matsushima A; Matsuda A; Yasuda H; Yamashita K; Egi M
    Thromb Res; 2018 Nov; 171():136-142. PubMed ID: 30312798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies.
    Papageorgiou C; Jourdi G; Adjambri E; Walborn A; Patel P; Fareed J; Elalamy I; Hoppensteadt D; Gerotziafas GT
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):8S-28S. PubMed ID: 30296833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of disseminated intravascular coagulation associated with hematologic malignancy and its response to recombinant human thrombomodulin.
    Kurita N; Sakamoto T; Kato T; Kusakabe M; Yokoyama Y; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    Thromb Res; 2019 Jan; 173():57-64. PubMed ID: 30472436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
    Asakura H; Takahashi H; Tsuji H; Matsushita T; Ninomiya H; Honda G; Mimuro J; Eguchi Y; Kitajima I; Sakata Y
    Thromb Res; 2014 Mar; 133(3):364-70. PubMed ID: 24440141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit Profile of Thrombomodulin Alfa Combined with Antithrombin Concentrate in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
    Murao A; Kato T; Yamane T; Honda G; Eguchi Y
    Clin Appl Thromb Hemost; 2022; 28():10760296221077096. PubMed ID: 35166576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of recombinant human soluble thrombomodulin treatment for disseminated intravascular coagulation at a single institution--an analysis of 62 cases caused by infectious diseases and 30 cases caused by hematological diseases.
    Kawano N; Tasaki A; Kuriyama T; Tahara Y; Yoshida S; Ono N; Himeji D; Yamashita K; Shibata Y; Goto T; Inoue T; Yokota-Ikeda N; Uezono S; Yuge A; Nishiguchi T; Kinjo T; Ogura Y; Beppu K; Ueda Y; Kinoshita M; Moritake H; Shimoda K; Ochiai H; Ueda A
    Intern Med; 2014; 53(3):205-13. PubMed ID: 24492688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The efficacy of early use of recombinant soluble thrombomodulin for disseminated intravascular coagulation complicated with hematologic malignancies].
    Usami M; Kuroda H; Yoshida M; Sakamoto H; Shimoyama S; Kanari Y; Yamada M; Abe T; Fujii S; Maeda M
    Rinsho Ketsueki; 2015 Jun; 56(6):673-80. PubMed ID: 26256878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic criteria and laboratory tests for disseminated intravascular coagulation.
    Kaneko T; Wada H
    J Clin Exp Hematop; 2011; 51(2):67-76. PubMed ID: 22104305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation.
    Kobayashi T; Kajiki M; Nihashi K; Honda G
    Thromb Res; 2017 Nov; 159():109-115. PubMed ID: 29153952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
    Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
    World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti DIC therapy].
    Yahata M; Sakamoto Y
    Nihon Rinsho; 2016 Feb; 74(2):257-61. PubMed ID: 26915249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Japanese consensus for disseminated intravascular coagulation (DIC): is it a small world after all?
    Levi M
    Thromb Res; 2010 Jan; 125(1):4-5. PubMed ID: 19735937
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
    Ikezoe T
    Int J Hematol; 2014 Jul; 100(1):27-37. PubMed ID: 24217998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.